Allogene Therapeutics Inc... (ALLO)
NASDAQ: ALLO
· Real-Time Price · USD
1.10
0.03 (2.80%)
At close: Aug 15, 2025, 3:59 PM
1.12
1.36%
After-hours: Aug 15, 2025, 07:51 PM EDT
Allogene Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | 22K | -44K | 22K | 22K | 30K | 47K | 49K | 86K | 61K | 51K | 49K | 44K | 38.34M |
Cost of Revenue | n/a | 3.1M | 3.23M | 3.21M | 3.64M | 3.56M | 3.48M | 3.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -3.1M | -3.23M | -3.21M | -3.64M | 22K | -44K | -3.55M | 22K | 30K | 47K | 49K | 86K | 61K | 51K | 49K | 44K | 38.34M |
Operating Income | -56.82M | -65.19M | -60.49M | -71.77M | -71.43M | -69.5M | -85.17M | -63M | -80.54M | -99.09M | -96.37M | -82.49M | -76.59M | -79.99M | -73.89M | -77.67M | -71.03M | -33.2M |
Interest Income | n/a | 5.52M | 3.03M | 6.71M | 4.99M | 5.43M | 6.26M | 6.21M | 3.78M | 2.06M | 2.76M | 1M | 315K | 492K | 186K | 393K | 624K | 511K |
Pretax Income | -50.94M | -59.73M | -59.5M | -66.29M | -66.36M | -65M | -89.26M | -62.29M | -79.23M | -99.97M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M | -70.94M | -33.02M |
Net Income | -50.94M | -59.73M | -59.94M | -66.29M | -66.36M | -65M | -89.62M | -62.29M | -79.23M | -99.97M | -94.85M | -83.15M | -74.79M | -79.85M | -74.87M | -78.19M | -70.94M | -33.02M |
Selling & General & Admin | 14.28M | 14.99M | 15.52M | 16.33M | 16.09M | 17.27M | 17.22M | 17.04M | 18.52M | 18.88M | 21M | 18.9M | 19.51M | 19.9M | 19.96M | 19M | 18.78M | 16.36M |
Research & Development | 40.16M | 50.2M | 44.97M | 44.71M | 50.35M | 52.26M | 54.66M | 45.98M | 62.04M | 80.24M | 75.42M | 63.64M | 57.17M | 60.16M | 53.98M | 58.72M | 52.29M | 55.18M |
Other Expenses | 2.38M | n/a | n/a | 10.73M | 4.99M | n/a | 13.24M | -3.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 56.82M | 65.19M | 60.49M | 71.77M | 71.43M | 69.53M | 85.13M | 59.45M | 80.56M | 99.12M | 96.42M | 82.54M | 76.68M | 80.05M | 73.94M | 77.72M | 71.07M | 71.55M |
Interest Expense | -268K | 150K | 81K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 65.19M | 60.49M | 71.77M | 71.43M | 69.53M | 85.13M | 63.02M | 80.56M | 99.12M | 96.42M | 82.54M | 76.68M | 80.05M | 73.94M | 77.72M | 71.07M | 71.55M |
Income Tax Expense | n/a | n/a | 443K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 218.93M | 215.36M | 210.57M | 209.19M | 190.03M | 169.13M | 168.34M | 167.65M | 146.8M | 144.56M | 144.15M | 143.66M | 143.38M | 141.36M | 139.17M | 137.03M | 134.83M | 132.16M |
Shares Outstanding (Diluted) | 218.93M | 215.36M | 210.57M | 209.19M | 190.03M | 169.13M | 168.34M | 167.65M | 146.8M | 144.56M | 144.15M | 143.66M | 143.38M | 141.36M | 139.17M | 137.03M | 134.83M | 132.16M |
EPS (Basic) | -0.23 | -0.28 | -0.28 | -0.32 | -0.35 | -0.38 | -0.51 | -0.37 | -0.54 | -0.68 | -0.66 | -0.58 | -0.52 | -0.56 | -0.54 | -0.57 | -0.53 | -0.25 |
EPS (Diluted) | -0.23 | -0.28 | -0.28 | -0.32 | -0.35 | -0.38 | -0.51 | -0.37 | -0.54 | -0.68 | -0.66 | -0.58 | -0.52 | -0.56 | -0.54 | -0.57 | -0.53 | -0.25 |
EBITDA | -56.82M | -56.48M | -56.18M | -62.99M | -62.8M | -61.45M | -68.45M | -58.72M | -76.9M | -95.58M | -93.31M | -78.63M | -72.92M | -76.3M | -69.65M | -75.34M | -69.06M | -31.28M |
EBIT | n/a | -59.58M | -59.41M | -66.19M | -66.44M | -65M | -71.86M | -62.29M | -80.54M | -99.09M | -96.37M | -82.49M | -76.59M | -79.99M | -73.89M | -77.67M | -71.03M | -33.2M |
Depreciation & Amortization | n/a | 3.1M | 3.23M | 3.21M | 3.64M | 3.56M | 3.48M | 3.57M | 3.64M | 3.51M | 3.07M | 3.86M | 3.67M | 3.69M | 4.24M | 2.33M | 1.96M | 1.92M |